Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

2.

Reply: Two cases of CLIPPERS with increased number of perivascular CD20-positive B lymphocytes.

Tobin WO, Guo Y, Keegan BM.

Brain. 2018 Oct 1;141(10):e76. doi: 10.1093/brain/awy236. No abstract available.

PMID:
30203037
3.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

PMID:
30055153
4.

Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Mult Scler. 2018 Oct;24(11):1445-1452. doi: 10.1177/1352458518781979. Epub 2018 Jul 26.

PMID:
30047830
5.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

PMID:
30014148
6.

Reply to: "Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis".

Tobin WO, Keegan BM.

Ocul Immunol Inflamm. 2018 Jun 29:1-2. doi: 10.1080/09273948.2018.1484497. [Epub ahead of print] No abstract available.

PMID:
29958047
7.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Sechi E, Keegan BM, Flanagan EP.

Lancet Neurol. 2018 Jun;17(6):498-499. doi: 10.1016/S1474-4422(18)30166-2. No abstract available.

PMID:
29778359
8.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
9.

Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis.

Jolliffe EA, Keegan BM, Flanagan EP.

Mult Scler Relat Disord. 2018 Jul;23:7-8. doi: 10.1016/j.msard.2018.04.012. Epub 2018 Apr 21.

PMID:
29709797
10.

Clinical Reasoning: A 30-year-old man with headache and sleep disturbance.

English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL.

Neurology. 2018 Apr 24;90(17):e1535-e1540. doi: 10.1212/WNL.0000000000005356. No abstract available.

PMID:
29686126
11.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

12.

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses.

Zalewski NL, Flanagan EP, Keegan BM.

Neurology. 2018 Jan 9;90(2):e96-e102. doi: 10.1212/WNL.0000000000004796. Epub 2017 Dec 15.

PMID:
29247071
13.

Reply: A case of CLIPPERS challenging the new diagnostic criteria.

Tobin WO, Guo Y, Krecke KN, Keegan BM.

Brain. 2018 Feb 1;141(2):e13. doi: 10.1093/brain/awx336. No abstract available.

PMID:
29244097
14.

Reply: CLIPPERS, a possible symptomatic lymphohistiocytic immune reaction.

Tobin WO, Guo Y, Keegan BM.

Brain. 2018 Jan 1;141(1):e6. doi: 10.1093/brain/awx299. No abstract available.

PMID:
29161360
15.

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM.

Brain. 2017 Sep 1;140(9):2415-2425. doi: 10.1093/brain/awx200.

PMID:
29050399
16.

Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.

Blume LC, Patten T, Eldeeb K, Leone-Kabler S, Ilyasov AA, Keegan BM, O'Neal JE, Bass CE, Hantgan RR, Lowther WT, Selley DE, Howlett AL.

Mol Pharmacol. 2017 Feb;91(2):75-86. doi: 10.1124/mol.116.104638. Epub 2016 Nov 28.

17.

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Neurology. 2016 Oct 18;87(16):1713-1719. Epub 2016 Sep 16.

18.

Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

Konno T, Broderick DF, Mezaki N, Isami A, Kaneda D, Tashiro Y, Tokutake T, Keegan BM, Woodruff BK, Miura T, Nozaki H, Nishizawa M, Onodera O, Wszolek ZK, Ikeuchi T.

AJNR Am J Neuroradiol. 2017 Jan;38(1):77-83. doi: 10.3174/ajnr.A4938. Epub 2016 Sep 15.

19.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

20.

Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.

Scharf EL, Hanson CA, Howard MT, Keegan BM.

J Neurooncol. 2016 Aug;129(1):77-83. doi: 10.1007/s11060-016-2140-y. Epub 2016 May 9.

PMID:
27161251
21.

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.

Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG.

Ann Neurol. 2016 Mar;79(3):437-47. doi: 10.1002/ana.24582. Epub 2016 Feb 12.

PMID:
26677112
22.

Diagnostic Yield and Safety of Cerebellar and Brainstem Parenchymal Biopsy.

Tobin WO, Meyer FB, Keegan BM.

World Neurosurg. 2015 Dec;84(6):1973-6. doi: 10.1016/j.wneu.2015.08.062. Epub 2015 Sep 2.

PMID:
26342777
23.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

24.

Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology.

Pichler MR, Flanagan EP, Aksamit AJ, Leavitt JA, Salomão DR, Keegan BM.

Neurol Clin Pract. 2015 Jun;5(3):216-223. doi: 10.1212/CPJ.0000000000000133.

25.

Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Keegan BM, Beveridge TJ, Pezor JJ, Xiao R, Sexton T, Childers SR, Howlett AC.

Neuropharmacology. 2015 Aug;95:492-502. doi: 10.1016/j.neuropharm.2015.02.021. Epub 2015 Feb 25.

26.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

27.

Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem.

Flanagan EP, Knopman DS, Keegan BM.

Neurol Clin Pract. 2014 Jun;4(3):226-230.

28.

In reply--Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.

Keegan BM, Flanagan EP.

Mayo Clin Proc. 2014 Jun;89(6):859. doi: 10.1016/j.mayocp.2014.03.009. No abstract available.

PMID:
24943702
29.

Specific pattern of gadolinium enhancement in spondylotic myelopathy.

Flanagan EP, Krecke KN, Marsh RW, Giannini C, Keegan BM, Weinshenker BG.

Ann Neurol. 2014 Jul;76(1):54-65. doi: 10.1002/ana.24184. Epub 2014 Jun 14.

PMID:
24838831
30.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

31.

[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.

Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM.

Mayo Clin Proc. 2013 Nov;88(11):1204-12. doi: 10.1016/j.mayocp.2013.07.019.

PMID:
24182701
32.

Amyloid-β-related angiitis presenting as a uveomeningeal syndrome.

Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH.

Neurology. 2013 Nov 12;81(20):1796-8. doi: 10.1212/01.wnl.0000435560.00234.a7. Epub 2013 Oct 16.

PMID:
24132378
33.

Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder.

Flanagan EP, Aksamit AJ, Kumar N, Morparia NP, Keegan BM, Weinshenker BG.

Neurol Clin Pract. 2013 Oct;3(5):448-451. doi: 10.1212/CPJ.0b013e3182a78f82. No abstract available.

34.

Therapeutic decision making in a new drug era in multiple sclerosis.

Keegan BM.

Semin Neurol. 2013 Feb;33(1):5-12. doi: 10.1055/s-0033-1345709. Epub 2013 May 25. Review.

PMID:
23709208
35.

Current and emerging therapies for multiple sclerosis.

Keegan BM.

Semin Neurol. 2013 Feb;33(1):3. doi: 10.1055/s-0033-1345711. Epub 2013 May 25. No abstract available.

PMID:
23709207
36.

Sjogren's syndrome with trigeminal neuropathy: motor involvement.

Flanagan EP, Kaufmann TJ, Keegan BM.

Pract Neurol. 2013 Oct;13(5):340-2. doi: 10.1136/practneurol-2013-000560. Epub 2013 May 23. No abstract available.

PMID:
23703941
37.

Paraneoplastic myelopathy.

Flanagan EP, Keegan BM.

Neurol Clin. 2013 Feb;31(1):307-18. doi: 10.1016/j.ncl.2012.09.001. Review.

PMID:
23186906
38.

Cutting-edge questions about CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids).

Keegan BM, Pittock SJ.

Arch Neurol. 2012 Jul;69(7):819-20. doi: 10.1001/archneurol.2012.1015. No abstract available.

PMID:
22777258
39.

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH.

Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.

40.

Outcomes after percutaneous surgery for patients with multiple sclerosis-related trigeminal neuralgia.

Mallory GW, Atkinson JL, Stien KJ, Keegan BM, Pollock BE.

Neurosurgery. 2012 Sep;71(3):581-6; discussion 586. doi: 10.1227/NEU.0b013e31825e795b.

PMID:
22592326
41.

A case of necrotizing myopathy with proximal weakness and cardiomyopathy.

Matthews E, Plotz PH, Portaro S, Parton M, Elliott P, Humbel RL, Holton JL, Keegan BM, Hanna MG.

Neurology. 2012 May 8;78(19):1527-32. doi: 10.1212/WNL.0b013e3182553baa. No abstract available.

PMID:
22565568
42.

A 21-year-old woman with multiple cancers and a new brain lesion.

Schiff D, Lam EM, Parisi JE, Giannini C, Uhm JH, Keegan BM, Kantarci OH.

Neurology. 2012 Mar 6;78(10):743-9. doi: 10.1212/WNL.0b013e318248e59c. No abstract available.

PMID:
22391604
43.

Progressive multifocal leukoencephalopathy in a patient treated with etanercept.

Graff-Radford J, Robinson MT, Warsame RM, Matteson EL, Eggers SD, Keegan BM.

Neurologist. 2012 Mar;18(2):85-7. doi: 10.1097/NRL.0b013e318247b868.

PMID:
22367837
44.

Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion.

Schmalstieg WF, Keegan BM, Weinshenker BG.

Neurology. 2012 Feb 21;78(8):540-4. doi: 10.1212/WNL.0b013e318247cc8c. Epub 2012 Feb 8.

PMID:
22323754
45.

Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM.

J Neurooncol. 2012 May;107(3):575-80. doi: 10.1007/s11060-011-0781-4. Epub 2011 Dec 22.

PMID:
22189600
46.

An enhancing brainstem lesion in a patient with a history of worldwide travel.

Roos KL, Gerdes LA, Kurz K, Kretzschmar H, Kümpfel T, Parisi JE, Keegan BM.

Neurology. 2011 Nov 8;77(19):1756-60. doi: 10.1212/WNL.0b013e318236eec2. No abstract available.

PMID:
22067962
47.

Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Wootla B, Denic A, Keegan BM, Winters JL, Astapenko D, Warrington AE, Bieber AJ, Rodriguez M.

Neurol Res Int. 2011;2011:780712. doi: 10.1155/2011/780712. Epub 2011 Sep 22.

48.

Primary intramedullary spinal cord lymphoma.

Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM.

Neurology. 2011 Aug 23;77(8):784-91. doi: 10.1212/WNL.0b013e31822b00b9. Epub 2011 Aug 10.

PMID:
21832220
49.

A middle-aged woman with nausea, weight loss, and orthostatic hypotension.

Singer W, Yung IO, Wollmann R, Kelly T, Keegan BM.

Neurology. 2011 Aug 2;77(5):489-95. doi: 10.1212/WNL.0b013e318227b18a. No abstract available.

PMID:
21810698
50.

Natalizumab for multiple sclerosis: a complicated treatment.

Keegan BM.

Lancet Neurol. 2011 Aug;10(8):677-8. doi: 10.1016/S1474-4422(11)70150-8. No abstract available.

PMID:
21777819

Supplemental Content

Loading ...
Support Center